ALIVAS
Alivas is a medical company that develops new therapeutic medical devices for refractory constipation. It is a joint venture between Stanford University and the University of Tokyo with the Japan Biodesign program for innovative medical device creation. The company was founded in 2017 and is based in Hongo, Tokyo in Japan.
ALIVAS
Social Links:
Industry:
Biotechnology Medical Medical Device Therapeutics
Founded:
2017-01-01
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.alivas.co.jp
Total Employee:
1+
Status:
Active
Contact:
03-5615-9966
Email Addresses:
[email protected]
Total Funding:
290 M JPY
Technology used in webpage:
Google Google Cloud PHP Wix
Similar Organizations
Applause Pharma
Aogochi is a technology-based company that develops therapeutic drugs and applications for medical care and pharmaceuticals.
Ascendant Biotech
Ascendant Biotech is a research company that offers gene therapy, immunotherapy, regenerative medicine, and medical devices.
Atems
Atems is a regeneration therapy company that develops regenerative medicine and biomedical devices.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Investors List
DBJ Capital
DBJ Capital investment in Series A - Alivas
MedVenture Partners
MedVenture Partners investment in Series A - Alivas
MedVenture Partners
MedVenture Partners investment in Series A - Alivas
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Seed Round - Alivas
Official Site Inspections
http://www.alivas.co.jp Semrush global rank: 7.28 M Semrush visits lastest month: 825
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Alivas"
Alivas Inc.
Apr 18, 2023 Alivasは米国最大の医療機器アクセラレーションプログラムであるMedTech Innovator US programにおいて1100社以上の応募社の中から上位20%として選抜され …See details»
Alivas Inc. - J-Startup
METI. Ministry of Economy, Trade and Industry Innovation and Environment Policy Bureau Innovation and Startup Promotion Division. 1-3-1 Kasumigaseki, Chiyoda-ku, Tokyo, 100-8901 …See details»
Alivas Inc.
Chronic constipation is a common condition affecting 14 percent of the general population. The level of decline in QOL is considered to be equivalent to that caused by rheumatoid arthritis.See details»
Alivas - Crunchbase Company Profile & Funding
Organization. Alivas . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Alivas is a medical company that develops new …See details»
株式会社Alivas - J-Startup
METI. 経済産業省 イノベーション・環境局 イノベーション創出新事業推進課 スタートアップ推進室 〒100-8901 東京都千代田区霞ヶ関 1-3-1 ※以下メールアドレス宛にお問い合わせいた …See details»
Alivas Company Profile | Management and Employees List
Find contact information for Alivas. Learn about their Research & Development, Business Services market share, competitors, and Alivas's email format. Company Overview. Team …See details»
Alivas - Products, Competitors, Financials, Employees, …
Headquarters Location. 7-3-1 Honjo, Bunkyo-ku 113-8485 No. 361, Amato Minami Research Building. Tokyo, 100-8901, Japan +81 356159966See details»
Alivas Inc. - VentureRadar
Polar Star Space CO.,Ltd Japan Privately Held Polar Star Space is a venture company started by Hokkaido University that utilizes the technologies of Hokkaido University, Tohoku University …See details»
株式会社Alivasの会社情報と資金調達 | NIKKEI COMPASS - 日本経 …
【NIKKEI COMPASS】株式会社Alivasは、難治性便秘に対する治療用医療機器の研究・開発を行うヘルスケアスタートアップ。 国内で 1000万人以上が便秘 ...See details»
Alivas - Overview, News & Similar companies | ZoomInfo.com
View Alivas (www.alivas.co.jp) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ... Alivas Inc is a …See details»
Alivas Company Profile 2024: Valuation, Funding
Alivas General Information Description. Developer of therapeutic medical device designed to treat refractory constipation in patients. The company's device offers treatment methods for intractable chronic constipation refractory, enabling …See details»
ALIVAS, K.K. Company Profile | BUNKYO-KU, TOKYO, Japan
Find company research, competitor information, contact details & financial data for ALIVAS, K.K. of BUNKYO-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
第一回起業支援プログラムで採択された株式会社Alivas - 東 …
第一回起業支援プログラムで採択された株式会社Alivas の田島CEOへお話を伺ってきました。 田島CEOは現役の医師でもあります。 東京都の先端利用機器アクセラレーションプロジェク …See details»
株式会社Alivas｜スピーダ スタートアップ情報リサーチ
Alivas、第三者割当増資を実施 シリーズBラウンドにて約3.5億円を調達 資金調達 2020/07/20 Alivas、第三者割当増資を実施 シリーズA追加資金として約1.9億円を調達See details»
株式会社Alivas - TOKYO GEEKS
Apr 21, 2023 株式会社Alivas 難治性便秘に対する新治療用医療機器の開発を行う。 CEO. 田島知幸 Founded. 2017/08/30 Capital. 9,698万8041円See details»
Alivas, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Alivas, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
株式会社Alivas、追加で第3者割当増資を行い、総額約2.9億円の資 …
Jul 21, 2020 「未来2018」ファイナリストの株式会社 Alivasは MedVenture Partners株式会社、および DBJキャピタル株式会社がそれぞれ管理・運営するファンドを引受先とする第三者割 …See details»
株式会社Alivasが約1億円の資金調達（シリーズAラウンド）を実施
Mar 18, 2020 株式会社Alivasが約1億円の資金調達（シリーズAラウンド）を実施 2020年3月18日 「未来2018」ファイナリストの株式会社Alivasが、MedVenture Partners 株式会社が管 …See details»
Alivas - Contacts, Employees, Board Members, Advisors & Alumni
Alivas is a medical company that develops new therapeutic medical devices for refractory constipation.See details»
Additional Investment in Alivas, Inc. - MedVenture Partners株式会社
Jul 20, 2020 JP / EN; Press Release. Press Release 2020.07.20. Additional Investment in Alivas, Inc. MPI-2 Investment Limited Partnership (MPI), managed and operated by …See details»